SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

8.86
Delayed Data
As of Mar 31
 -0.09 / -1.01%
Today’s Change
4.24
Today|||52-Week Range
9.65
+1.14%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close8.95
Today’s open8.96
Day’s range-- - --
Volume454,674
Average volume (3 months)348,665
Market cap$448.0M
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)+18.75%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio18.5
Price/Sales3.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IGIGI Laboratories Inc-0.29-3.43%
XNPTXenoport Inc-0.14-1.93%
NWBONorthwest Biotherape...-0.09-1.21%
PRTKParatek Pharmaceutic...+0.96+3.17%
Data as of 03/31/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)$0.10
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account